Oracle Associates LLC - Insider Trading Tracker

Abeona 治療公司

US ˙ NasdaqCM ˙ US00289Y2063

簡介

本頁面提供了有關 Oracle Associates LLC 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。盡管存在這些限制，學術研究表明，內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易，排除了作為10b5-1交易計劃的一部分的交易。然後，對每筆交易在3、6和12個月的表現進行平均，以生成該筆交易最終的表現指標。最終，將所有交易的表現指標進行平均，計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A"，則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易，或者他們進行的交易距離現在太近，無法計算出可靠的表現指標。

更新頻率：每日

查看收益最高的的內幕交易者列表。

查看排名最高的內部人士。

報告內部持倉的公司

SEC文件顯示Oracle Associates LLC已報告在以下公司擁有持倉或進行了交易：

證券	職位	最新報告的持倉
US:SLNO / Soleno Therapeutics, Inc.	10% Owner	4,016,283
US:BIOL / BIOLASE, Inc.	10% Owner	30,866,265
US:VRML / Vermillion, Inc.	10% Owner	0
US:HNSN / Hansen Medical, Inc.	10% Owner	0
US:ACCP /	10% Owner	119,811

如何解讀這些圖表

以下圖表顯示了在Oracle Associates LLC進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如，如果一筆內部人士交易是在2019年1月1日進行的，該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元，則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%，而從10美元跌至5美元的價格變化將為-50%。

最終，我們將評估內部人士的交易與股價的超額回報（正向或負向）之間的相關性，以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為，我們預期看到（a）購買後的正回報，或者（b）賣出後的負回報。對於情況（a），購買圖表將顯示一系列向上傾斜的曲線，表示每次購買後都有正回報。對於情況（b），賣出圖表將顯示一系列向下傾斜的曲線，表示每次賣出後都有負回報。

然而，僅憑這一點還不足以得出結論。例如，如果公司的股價在多年內呈現非周期性上升，我們會預期所有購買後的圖表都呈現向上傾斜。同樣地，多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下，「購買」圖表顯示正向信號，而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易，以獲得財務優勢。

ABEO / Abeona Therapeutics Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 ABEO / Abeona Therapeutics Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	證券代碼	內部人士	報告股數	Reported 價格	經調整股數	經調整價格	成本基礎	達到最高利潤的天數
2008-02-12	ACCP	FEINBERG LARRY N	29,736	3.1500	29,736	3.1500	93,668	731
2007-06-19	ACCP	FEINBERG LARRY N	60,000	5.1700	60,000	5.1700	310,200
2007-01-22	ACCP	FEINBERG LARRY N	6,040	2.5300	6,040	2.5300	15,281
2005-12-31	ACCP	FEINBERG LARRY N	15,636	0.6500	15,636	0.6500	10,163
2005-12-31	ACCP	FEINBERG LARRY N	82,745	0.6500	82,745	0.6500	53,784
2005-12-31	ACCP	FEINBERG LARRY N	299,056	0.6500	299,056	0.6500	194,386
2005-12-31	ACCP	FEINBERG LARRY N	78,184	0.6500	78,184	0.6500	50,820
2005-02-01	ACCP	FEINBERG LARRY N	30,200	2.6900	30,200	2.6900	81,238

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ABEO / Abeona Therapeutics Inc. Insider Trades

ABEO / Abeona Therapeutics Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 ABEO / Abeona Therapeutics Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	證券代碼	內部人士	報告股數	Reported 價格	經調整股數	經調整價格	成本基礎	達到最低利潤的天數
2008-02-12	ACCP	FEINBERG LARRY N	29,736	3.1500	29,736	3.1500	93,668	731
2007-07-24	ACCP	FEINBERG LARRY N	2,040	4.3500	2,040	4.3500	8,874
2007-07-23	ACCP	FEINBERG LARRY N	4,000	4.3563	4,000	4.3563	17,425
2007-06-19	ACCP	FEINBERG LARRY N	40,000	5.1700	40,000	5.1700	206,800
2007-06-19	ACCP	FEINBERG LARRY N	20,000	5.1700	20,000	5.1700	103,400
2007-03-01	ACCP	FEINBERG LARRY N	1,200	7.1250	1,200	7.1250	8,550
2007-02-28	ACCP	FEINBERG LARRY N	10,000	7.1000	10,000	7.1000	71,000
2007-02-28	ACCP	FEINBERG LARRY N	4,500	7.1000	4,500	7.1000	31,950
2007-02-27	ACCP	FEINBERG LARRY N	300	7.0000	300	7.0000	2,100
2007-02-27	ACCP	FEINBERG LARRY N	100	7.0000	100	7.0000	700
2007-02-26	ACCP	FEINBERG LARRY N	19,000	7.3140	19,000	7.3140	138,966
2007-02-26	ACCP	FEINBERG LARRY N	5,000	7.3140	5,000	7.3140	36,570
2007-02-26	ACCP	FEINBERG LARRY N	1,000	7.3140	1,000	7.3140	7,314
2007-01-22	ACCP	FEINBERG LARRY N	6,040	2.5300	6,040	2.5300	15,281
2006-09-01	ACCP	FEINBERG LARRY N	1		1
2006-09-01	ACCP	FEINBERG LARRY N	0		0
2006-09-01	ACCP	FEINBERG LARRY N	0		0
2005-02-01	ACCP	FEINBERG LARRY N	30,200	2.6900	30,200	2.6900	81,238

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AWHL / Aspira Women's Health Inc.內部人士買入 - 短期收益分析

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	證券代碼	內部人士	報告股數	Reported 價格	經調整股數	經調整價格	成本基礎	達到最高利潤的天數
2017-02-17	VRML	FEINBERG LARRY N	617,731	1.4000	617,731	1.4000	864,823	304
2015-07-14	VRML	FEINBERG LARRY N	510,204	1.9600	510,204	1.9600	1,000,000
2015-07-14	VRML	FEINBERG LARRY N	1,839	1.9054	1,839	1.9054	3,504
2014-12-23	VRML	FEINBERG LARRY N	972,222	1.4400	972,222	1.4400	1,400,000

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AWHL / Aspira Women's Health Inc. Insider Trades

AWHL / Aspira Women's Health Inc.內部人士賣出 - 短期虧損分析

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	證券代碼	內部人士	報告股數	Reported 價格	經調整股數	經調整價格	成本基礎	達到最低利潤的天數	達到最低利潤時的價格	避免的最高損失金額($)	避免的最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

歷史內部人交易

該表格顯示了由 Oracle Associates LLC 進行的所有內幕交易的完整列表，這些交易已向美國證券交易委員會（SEC）披露。

呈報日期	交易日期	表格	證券代碼	證券	代碼	股份	剩餘股份	% 變化	每股股價	交易金額	剩餘金額
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-06	2017-12-05	4	BIOL	BIOLASE, INC Common Stock	P - Purchase	10,745,615	30,866,265	53.41	0.46	4,900,000	14,075,017
2017-12-06	2017-12-04	4	BIOL	BIOLASE, INC Common Stock	P - Purchase	1,800,000	20,120,650	9.82	0.30	540,000	6,036,195
2017-08-31	2017-08-31	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	X - Other	-583,333	0	-100.00
2017-08-31	2017-08-31	4	VRML	VERMILLION, INC. Common Stock	X - Other	583,333	9,825,289	6.31	1.00	583,333	9,825,289
2017-08-30	2017-08-25	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	P - Purchase	583,333	583,333
2017-08-30	2017-08-25	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	H - Other	-583,333	0	-100.00
2017-07-05	2017-06-30	4	BIOL	BIOLASE, INC Warrants to acquire Common Stock	P - Purchase	1,800,535	3,144,811	133.94	0.12	225,067	393,101
2017-07-05	2017-06-30	4	BIOL	BIOLASE, INC Series D Preferred Stock	C - Conversion	-36,986	0	-100.00
2017-07-05	2017-06-30	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	3,698,600	18,320,650	25.29	1.24	4,586,264	22,717,606
2017-02-17	2017-02-17	4	VRML	VERMILLION, INC. Warrant to acquire Common Stock	P - Purchase	1	0	-100.00
2017-02-17	2017-02-17	4	VRML	VERMILLION, INC. Common Stock, par value $0.001 per share	P - Purchase	617,731	9,825,289	6.71	1.40	864,823	13,755,405
2016-12-06	2016-12-05	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	46,463	14,608,464	0.32	1.85	85,957	27,025,658
2016-12-06	2016-12-02	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	53,537	14,562,001	0.37	1.78	95,296	25,920,362
2016-11-17	2016-11-16	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	33,674	14,508,464	0.23	1.71	57,583	24,809,473
2016-11-17	2016-11-15	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	18,514	14,478,326	0.13	1.72	31,844	24,902,721
2016-11-14	2016-11-14	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	33,674	14,459,812	0.23	1.61	54,215	23,280,297
2016-11-14	2016-11-11	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	48,513	14,426,138	0.34	1.81	87,809	26,111,310
2016-11-14	2016-11-10	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	42,000	14,377,625	0.29	1.81	76,020	26,023,501
2016-11-10	2016-11-09	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	125,000	14,335,625	0.88	1.70	212,500	24,370,562
2016-11-10	2016-11-08	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	2,000	14,230,625	0.01	1.52	3,040	21,630,550
2016-10-05	2016-09-30	4	BIOL	BIOLASE, INC Warrants to acquire Common Stock	P - Purchase	850,797	2,194,983	63.29
2016-10-05	2016-09-30	4	BIOL	BIOLASE, INC Series C Preferred Stock	C - Conversion	-37,091	0	-100.00
2016-10-05	2016-09-30	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	3,699,100	14,228,625	35.13	1.13	4,179,983	16,078,346
2016-08-10	2016-08-08	4	BIOL	BIOLASE, INC Series C Preferred Stock	P - Purchase	37,091	37,091		1.13	41,913	41,913
2016-08-10	2016-08-08	4	BIOL	BIOLASE, INC Warrants to acquire Common Stock	P - Purchase	850,797	2,194,983	63.29	0.12	106,350	274,373
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-22,659	0	-100.00	90,636.00	-2,053,721,124
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-19,050	0	-100.00	76,200.00	-1,451,610,000
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-3,950	0	-100.00	15,800.00	-62,410,000
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-492,846	0	-100.00	1,971,384.00	-971,588,718,864
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-854,377	0	-100.00	3,417,508.00	-2,919,840,232,516
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-3,090,732	0	-100.00	12,362,928.00	-38,210,497,183,296
2015-07-16	2015-07-14	4	VRML	VERMILLION, INC. Common Stock, par value $0.001 per share	P - Purchase	1,839	8,624,225	0.02	1.91	3,504	16,432,598
2015-07-16	2015-07-14	4	VRML	VERMILLION, INC. Common Stock, par value $0.001 per share	P - Purchase	510,204	8,624,225	6.29	1.96	1,000,000	16,903,481
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Series E Warrant	J - Other	2,308,000	2,308,000
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Series E Warrant	J - Other	3,846,000	3,846,000
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Series E Warrant	J - Other	12,308,000	12,308,000
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	P - Purchase	2,361,342	4,928,288	91.99	0.65	1,534,872	3,203,387
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	P - Purchase	3,934,886	8,543,465	85.38	0.65	2,557,676	5,553,252
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	P - Purchase	12,592,453	30,906,311	68.76	0.65	8,185,094	20,089,102
2014-12-29	2014-12-23	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	P - Purchase	583,333	0	-100.00
2014-12-29	2014-12-23	4	VRML	VERMILLION, INC. Common Stock, Par Value $0.001 per share	P - Purchase	972,222	8,112,182	13.62	1.44	1,400,000	11,681,542
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	X - Other	-652,724	0	-100.00
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	X - Other	-1,171,866	0	-100.00
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	X - Other	-4,656,852	0	-100.00
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	652,724	2,566,946	34.10	1.13	737,578	2,900,649
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	1,171,866	4,608,579	34.10	1.13	1,324,209	5,207,694
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	4,656,852	18,313,858	34.10	1.13	5,262,243	20,694,660
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series D Warrant	J - Other	200,712	200,712
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series D Warrant	J - Other	360,350	360,350
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series D Warrant	J - Other	1,431,983	1,431,983
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	J - Other	652,724	652,724
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	J - Other	1,171,866	1,171,866
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	J - Other	4,656,852	4,656,852
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B Warrant	J - Other	-326,362	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series C Warrant	J - Other	-326,362	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B Warrant	J - Other	-585,933	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series C Warrant	J - Other	-585,933	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B Warrant	J - Other	-2,382,426	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series C Warrant	J - Other	-2,382,426	0	-100.00
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Series A Warrant	X - Other	-326,362	0	-100.00
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Series A Warrant	X - Other	-585,933	0	-100.00
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Series A Warrant	X - Other	-2,328,426	0	-100.00
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	326,362	1,914,222	20.55	1.23	401,425	2,354,493
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	585,933	3,436,713	20.55	1.23	720,698	4,227,157
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	2,328,426	13,657,006	20.55	1.23	2,863,964	16,798,117
2013-12-23	2013-12-19	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	C - Conversion	-4,339,980	0	-100.00
2013-12-23	2013-12-19	4	VRML	VERMILLION, INC. Common Stock, par value $0.001 per share	C - Conversion	4,339,980	7,139,960	155.00
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series A Warrant	P - Purchase	326,362	326,362		0.12	40,795	40,795
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series C Warrant	P - Purchase	326,362	326,362		0.12	40,795	40,795
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series A Warrant	P - Purchase	585,933	585,933		0.12	73,242	73,242
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series C Warrant	P - Purchase	585,933	585,933		0.12	73,242	73,242
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series A Warrant	P - Purchase	2,328,426	2,328,426		0.12	291,053	291,053
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series C Warrant	P - Purchase	2,328,426	2,328,426		0.12	291,053	291,053
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series B Warrant	P - Purchase	326,362	326,362		0.12	40,795	40,795
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series B Warrant	P - Purchase	585,933	585,933		0.12	73,242	73,242
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series B Warrant	P - Purchase	2,328,426	2,328,426		0.12	291,053	291,053
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Common Stock, par value$0.0001 per share	P - Purchase	815,904	1,587,860	105.69	1.23	1,003,562	1,953,068
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Common Stock, par value$0.0001 per share	P - Purchase	1,464,842	2,850,780	105.69	1.23	1,801,756	3,506,459
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Common Stock, par value$0.0001 per share	P - Purchase	5,821,064	11,328,580	105.69	1.23	7,159,909	13,934,153
2013-05-23		3	VRML	VERMILLION, INC. Common Stock, par value $0.001			2,799,980
2008-06-10	2008-03-11	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock Purchase Warrants	S - Sale	119,811	119,811
2008-06-10	2008-03-11	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock Purchase Warrants	P - Purchase	119,811	119,811
2008-06-10	2008-03-11	4	ACCP	ACCESS PHARMACEUTICALS INC Series A Cumulative Convertible Preferred Stock	S - Sale	72	72
2008-06-10	2008-03-11	4	ACCP	ACCESS PHARMACEUTICALS INC Series A Cumulative Convertible Preferred Stock	P - Purchase	72	72
2008-06-10	2008-02-12	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-29,736	296,483	-9.12	3.15	-93,668	933,921
2008-06-10	2008-02-12	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	29,736	296,483	11.15	3.15	93,668	933,921
2008-06-10	2007-11-10	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock Purchase Warrants	J - Other	728,850	728,850
2008-06-10	2007-11-10	4	ACCP	ACCESS PHARMACEUTICALS INC Series A Cumulative Convertible Preferred Stock	J - Other	437	437
2008-06-10	2007-07-24	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-2,040	296,483	-0.68	4.35	-8,874	1,289,701
2008-06-10	2007-07-23	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-4,000	298,523	-1.32	4.36	-17,425	1,300,456
2008-06-10	2007-06-19	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	60,000	302,523	24.74	5.17	310,200	1,564,044
2008-06-10	2007-06-19	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-20,000	302,523	-6.20	5.17	-103,400	1,564,044
2008-06-10	2007-06-19	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-40,000	302,523	-11.68	5.17	-206,800	1,564,044
2008-06-10	2007-03-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-1,200	302,523	-0.40	7.12	-8,550	2,155,476
2008-06-10	2007-02-28	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-4,500	302,523	-1.47	7.10	-31,950	2,147,913
2008-06-10	2007-02-28	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-10,000	302,523	-3.20	7.10	-71,000	2,147,913
2008-06-10	2007-02-27	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-100	318,223	-0.03	7.00	-700	2,227,561
2008-06-10	2007-02-27	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-300	318,223	-0.09	7.00	-2,100	2,227,561
2008-06-10	2007-02-26	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-1,000	318,623	-0.31	7.31	-7,314	2,330,409
2008-06-10	2007-02-26	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-5,000	318,623	-1.55	7.31	-36,570	2,330,409
2008-06-10	2007-02-26	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-19,000	318,623	-5.63	7.31	-138,966	2,330,409
2008-06-10	2007-01-22	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	6,040	343,623	1.79	2.53	15,281	869,366
2008-06-10	2007-01-22	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-6,040	343,623	-1.73	2.53	-15,281	869,366
2008-06-10	2006-09-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-0	343,623	0.00
2008-06-10	2006-09-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-0	343,623	0.00
2008-06-10	2006-09-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-1	343,623	0.00
2008-06-10	2006-06-05	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	J - Other	-1,374,497	343,624	-80.00
2008-06-10	2005-12-31	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	78,184	1,718,121	4.77	0.65	50,820	1,116,779
2008-06-10	2005-12-31	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	299,056	1,718,121	21.07	0.65	194,386	1,116,779
2008-06-10	2005-12-31	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	82,745	1,718,121	5.06	0.65	53,784	1,116,779
2008-06-10	2005-12-31	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	15,636	1,718,121	0.92	0.65	10,163	1,116,779
2008-06-10	2005-02-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-30,200	1,242,500	-2.37	2.69	-81,238	3,342,325
2008-06-10	2005-02-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock, par value $0.01 per share ("Common Stock")	P - Purchase	30,200	1,242,500	2.49	2.69	81,238	3,342,325
2008-06-10		3	ACCP	ACCESS PHARMACEUTICALS INC Common Stock, par value $0.01 per share ("Common Stock")			900,400

非衍生或衍生證券的公開市場或私下買入

非衍生或衍生證券的公開市場或私下賣出

公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）

衍生工具轉換

將證券賣出或轉讓回公司

使用從公司收到的證券的一部分來支付行使價或稅務負擔。

內部人士贈送或接收他人贈送公司股票

股權掉期和類似的避險交易

行使或轉換從公司獲得的衍生證券（例如期權）

內部人士透過Form 4自願報告的一筆交易

其他（附有交易描述的腳註）